France vs Philippines: HIV/AIDS deaths averted by antiretroviral therapy
France
5,635 deaths
in 2022
Philippines
5,500 deaths
in 2024
France rank
32nd
Philippines rank
34th
HIV/AIDS deaths averted by antiretroviral therapy over time
- France
- Philippines
How they compare
France currently reports 5,635 deaths against 5,500 deaths in Philippines, a difference of 135 deaths.
The two have swapped places 1 time across 33 shared years of data; in 1990 it was Philippines ahead.
France ranks 32nd and Philippines ranks 34th of 157 countries.
France has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | France | Philippines | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 869.7 deaths | 0 deaths | 869.7 deaths | France |
| 2000s | 5,347 deaths | 23.06 deaths | 5,324 deaths | France |
| 2010s | 6,037 deaths | 1,105 deaths | 4,933 deaths | France |
| 2020s | 5,744 deaths | 3,693 deaths | 2,051 deaths | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, France or Philippines?
- France, at 5,635 deaths against 5,500 deaths in Philippines as of 2022.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between France and Philippines?
- 135 deaths, with France ahead.
- How many years of comparable data are there for France and Philippines?
- 33 years are reported by both, from 1990 to 2022.
- How do France and Philippines rank globally for hiv/aids deaths averted by antiretroviral therapy?
- France ranks 32nd and Philippines ranks 34th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.